Cymabay Therapeutics, Inc.

États‑Unis d’Amérique


Commandez votre montre hebdomadaire Cymabay Therapeutics, Inc.
Quantité totale PI 112
Rang # Quantité totale PI 11 961
Note d'activité PI 2,7/5.0    69
Rang # Activité PI 10 141
Symbole boursier
ISIN US23257D1037
Capitalisation 544M  (USD)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

39 11
10 14
21 2
15
 
Dernier brevet 2024 - Treatment of chronic pruritic de...
Premier brevet 1999 - Use of (-) (3-trihalomethylpheno...
Dernière marque 2025 - LYFDELZI
Première marque 2013 - CYMABAY

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S Pharmaceutical preparations for the treatment of liver diseases, autoimmune diseases and disorder...
P/S Pharmaceutical preparations for the treatment of liver diseases, autoimmune diseases and disorde...
P/S Pharmaceutical preparations and substances for the treatment of liver diseases; pharmaceutical pr...
P/S Pharmaceutical preparations.
2024 P/S Pharmaceutical preparations for treatment of autoimmune diseases and disorders; pharmaceutical pr...
P/S Pharmaceutical preparations for treatment of autoimmune diseases and disorders; pharmaceutical p...
P/S pharmaceutical preparations for treatment of autoimmune diseases and disorders; pharmaceutical pr...
P/S Pharmaceutical preparations and substances for the treatment of liver diseases.
P/S Pharmaceutical preparations and substances for the treatment of liver diseases.
Invention Treatment of chronic pruritic dermatoses. Treatment of chronic pruritic dermatoses by administrat...
Invention Treatment of uremic pruritus. Treatment of uremic pruritus by administration of seladelpar or a s...
Invention Treatment of uremic pruritus. Treatment of uremic pruritus by administration of seladelpar or a ...
Invention Treatment of chronic pruritic dermatoses. Treatment of chronic pruritic dermatoses by administra...
2023 P/S Pharmaceutical preparations and substances for the treatment of liver diseases
P/S Pharmaceutical preparations and substances for the treatment of liver diseases
2022 Invention Treatment of cholangiopathies. Seladelpar and its salts are useful in the treatment of cholangio...
Invention Treatment of cholangiopathies with seladelpar. Seladelpar and its salts are useful in the treatme...
2021 Invention Cb-0406 tromethamine salt. CB-0406 tromethamine salt, especially in crystalline form and as an an...
Invention Cb-0406 choline salt. CB-0406 choline salt, especially in crystalline form and as an ansolvate, m...
Invention Cb-0406 tromethamine salt. CB-0406 tromethamine salt, especially in crystalline form and as an a...
Invention Cb-0406 choline salt. CB-0406 choline salt, especially in crystalline form and as an ansolvate, ...
Invention Treatment of intrahepatic cholestatic diseases. Treatment of intrahepatic cholestatic diseases by...
2020 Invention Treatment of cholestatic pruritus. Treatment of cholestatic pruritus by therapy with seladelpar ...
Invention Treatment of alcoholic liver disease. Treatment of alcoholic liver disease with seladelpar or a ...
Invention Treatment of intestinal barrier dysfunction and associated diseases. Treatment of intestinal bar...
Invention Seladelpar for use in the treatment of alcoholic liver disease. Treatment of alcoholic liver dise...
Invention Seladelpar for use in the treatment of intestinal barrier dysfunction and associated diseases. Tr...
Invention Treatment of nafld and nash. Treatment of NAFLD and NASH by therapy with MBX-8025 or an MBX-8025 ...
2019 Invention Combination treatment of nafld and nash. Combination treatment of NAFLD, including NASH, with sel...
Invention Treatment of obesity and its complications. Combination treatment of obesity and its complication...
Invention Combination treatment of nafld and nash. Combination treatment of NAFLD, including NASH, with se...
Invention Treatment of obesity and its complications. Combination treatment of obesity and its complicatio...
P/S Pharmaceutical preparations and substances for the treatment of liver diseases. Pharmaceutical re...
P/S Pharmaceutical preparations and substances for the treatment of liver diseases Pharmaceutical res...
P/S Pharmaceutical research and development; laboratory research services relating to pharmaceuticals
2018 Invention Methods of reducing small, dense ldl particles. The present invention provides methods for increa...
Invention Treatment of cholestatic pruritus. Treatment of cholestatic pruritus by therapy with seladelpar o...
Invention Treatment for nafld and nash. Treatment of NAFLD and NASH by therapy with MBX-8025 or an MBX-8025...
2017 Invention Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a...
Invention Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestin...
Invention Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders. Compounds a...
Invention Treatment of severe hyperlipidemia. Treatment of severe hyperlipidemia by administration of selad...
2016 Invention Treatment of severe hyperlipidemia. Treatment of severe hyperlipidemia by administration of (R)-...
Invention Methods of reducing small, dense ldl particles. The present invention provides methods for incre...
2015 Invention Methods for treating gout flares. Methods of treating gout flares comprising administering a com...
2013 P/S Pharmaceutical research and development; Laboratory research services relating to pharmaceuticals